{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:52:57Z","timestamp":1761519177581},"reference-count":18,"publisher":"Impact Journals, LLC","issue":"28","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,7,11]]},"DOI":"10.18632\/oncotarget.15101","type":"journal-article","created":{"date-parts":[[2017,2,7]],"date-time":"2017-02-07T22:21:23Z","timestamp":1486506083000},"page":"46557-46564","source":"Crossref","is-referenced-by-count":5,"title":["Axillary staging in breast cancer patients treated with neoadjuvant chemotherapy in two Dutch phase III studies"],"prefix":"10.18632","volume":"8","author":[{"given":"Birgit E.P.","family":"Vriens","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"The Dutch Breast Cancer Research Group (BOOG)","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristien B.M.","family":"Keymeulen","sequence":"additional","affiliation":[{"name":"Department of Surgery, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith R.","family":"Kroep","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayoub","family":"Charehbili","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands"},{"name":"Department of Surgery, Leiden University Medical Center, Nijmegen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petronella G.","family":"Peer","sequence":"additional","affiliation":[{"name":"Biostatistics, Radboud Institute for Health Sciences, Nijmegen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maaike","family":"de Boer","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maureen J.B.","family":"Aarts","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther M.","family":"Heuts","sequence":"additional","affiliation":[{"name":"Department of Surgery, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivianne C.G.","family":"Tjan-Heijnen","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2017,2,4]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1016\/j.ejca.2013.06.012","article-title":"Doxorubicin\/cyclophosphamide with concurrent versus sequential docetaxel as neoadjuvant treatment in patients with breast cancer","volume":"49","author":"Tjan-Heijnen","year":"2013","journal-title":"European Journal of Cancer"},{"key":"2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.clbc.2013.12.015","article-title":"A model to predict pathologic complete response of axillary lymph nodes to neoadjuvant chemo(immuno)therapy in patients with clinically node-positive breast cancer","volume":"14","author":"Smidt","year":"2014","journal-title":"Clinical Breast Cancer"},{"key":"3","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1245\/s10434-012-2484-2","article-title":"The role for sentinel lymph node dissection after neoadjuvant chemotherapy in patients who present with node-positive breast cancer","volume":"19","author":"Hunt","year":"2012","journal-title":"Annals Surgical Oncology"},{"key":"4","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1016\/j.ejca.2009.08.001","article-title":"Accuracy of sentinel node biopsy after neoadjuvant chemotherapy in breast cancer patients: a systematic review","volume":"45","author":"van Diest","year":"2009","journal-title":"European Journal of Cancer"},{"key":"5","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","article-title":"Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study","volume":"14","author":"Staebler","year":"2013","journal-title":"Lancet Oncology"},{"key":"6","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2013.278932","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial","volume":"310","author":"Julian","year":"2013","journal-title":"The Journal of the American Medical Association"},{"key":"7","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1093\/annonc\/mdu102","article-title":"Addition of zoledronic acid to neoadjuvant chemotherapy does not enhance tumor response in patients with HER2-negative stage II\/III breast cancer: the NEOZOTAC trial","volume":"25","author":"van Laarhoven","year":"2014","journal-title":"Annals of Oncology"},{"key":"8","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/SLA.0000000000000551","article-title":"Factors affecting sentinel lymph node identification rate after neoadjuvant chemotherapy for breast cancer patients enrolled in ACOSOG Z1071 (Alliance)","volume":"261","author":"Hunt","year":"2015","journal-title":"Annals of Surgery"},{"key":"9","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/SLA.0000000000000558","article-title":"Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure","volume":"261","author":"Vrancken Peeters","year":"2015","journal-title":"Annals of Surgery"},{"key":"10","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1245\/s10434-007-9494-5","article-title":"Preoperative identification of the sentinel lymph node in breast cancer","volume":"14","author":"Kapke","year":"2007","journal-title":"Annals of Surgical Oncology"},{"key":"11","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/SLA.0000000000001375","article-title":"Identification and resection of clipped node decreases the false-negative rate of sentinel lymph node surgery in patients presenting with node-positive breast cancer (T0-T4, N1-2) who receive neoadjuvant chemotherapy. Results from ACOSOG Z1071 (Alliance)","volume":"263","author":"Hunt","year":"2016","journal-title":"Annals of Surgery"},{"key":"12","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1245\/s10434-014-4034-6","article-title":"Initial results with preoperative tattooing of biopsied axillary lymph nodes and correlation to sentinel lymph nodes in breast cancer patients","volume":"22","author":"Wapnir","year":"2015","journal-title":"Annals of Surgical Oncology"},{"key":"13","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1200\/JCO.2015.64.0094","article-title":"Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection","volume":"34","author":"Chavez-MacGregor","year":"2016","journal-title":"Joural of Clinical Oncology"},{"key":"14","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/SLA.0b013e3181b8fd5e","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast cancer patients","volume":"250","author":"Meric-Bernstam","year":"2009","journal-title":"Annals of Surgery"},{"key":"15","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.ejca.2015.03.014","article-title":"Population based study on sentinel node biopsy before or after neoadjuvant chemotherapy in clinically node negative breast cancer patients: Identification rate and influence on axillary treatment","volume":"51","author":"Rutgers","year":"2015","journal-title":"European Journal of Cancer"},{"key":"16","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trail","volume":"15","author":"Nieuwenhuijzen","year":"2014","journal-title":"Lancet Oncology"},{"key":"17","volume-title":"AJCC Cancer Staging Manual","author":"Trotti","year":"2010","edition":"7"},{"key":"18","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10549-010-1210-7","article-title":"Safety of avoiding routine use of axillary dissection in early stage breast cancer: a systematic review","volume":"125","author":"Tjan-Heijnen","year":"2011","journal-title":"Breast Cancer Research and Treatment"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.15101","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T19:15:06Z","timestamp":1658603706000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.15101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,4]]},"references-count":18,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2017,7,11]]}},"alternative-id":["15101","28177921"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.15101","relation":{},"ISSN":["1949-2553"],"issn-type":[{"type":"electronic","value":"1949-2553"}],"subject":[],"published":{"date-parts":[[2017,2,4]]}}}